High plasma adiponectin levels in patients with severe traumatic brain injury

Clinica Chimica Acta

Volumn 427, Issue , 2014, Pages 37-41

  Shen, Liang Jun ^a   Yang, Song Bin ^a   Lv, Qing Wei ^a   Zhang, Guo Hai ^a   Zhou, Jing ^a   Guo, Mi ^a   Huang, Hang Bin ^a   Li, Zhao ^a   Yang, Chun Song ^a  

^a Shengzhou People's Hospital   (China)

Author keywords

Adiponectin; Biomarker; Prognosis; Traumatic brain injury

Indexed keywords

ADIPONECTIN;

ADULT; ARTICLE; CONTROLLED STUDY; FEMALE; GLASGOW COMA SCALE; HUMAN; INJURY SEVERITY; MAJOR CLINICAL STUDY; MALE; MORTALITY; PREDICTIVE VALUE; PRIORITY JOURNAL; PROGNOSIS; PROTEIN BLOOD LEVEL; RECEIVER OPERATING CHARACTERISTIC; TRAUMATIC BRAIN INJURY; ADOLESCENT; AGED; BLOOD; BRAIN INJURIES; INJURY SCALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; YOUNG ADULT;

ADIPONECTIN; ADOLESCENT; ADULT; AGED; BRAIN INJURIES; FEMALE; HOSPITAL MORTALITY; HUMANS; INJURY SEVERITY SCORE; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; YOUNG ADULT;

EID: 84886266034     PISSN: 00098981     EISSN: 18733492     Source Type: Journal    
DOI: 10.1016/j.cca.2013.09.047     Document Type: Article

References (28)

1. Turer A.T., Scherer P.E. Adiponectin: mechanistic insights and clinical implications. Diabetologia 2012, 55:2319-2326.
2. Ohashi K., Ouchi N., Matsuzawa Y. Anti-inflammatory and anti-atherogenic properties of adiponectin. Biochimie 2012, 94:2137-2142.
3. Blaslov K., Bulum T., Zibar K., Duvnjak L. Relationship between adiponectin level, insulin sensitivity, and metabolic syndrome in type 1 diabetic patients. Int J Endocrinol 2013, 2013:535906.
4. Venkatesh B., Hickman I., Nisbet J., Cohen J., Prins J. Changes in serum adiponectin concentrations in critical illness: a preliminary investigation. Crit Care 2009, 13:R105.
5. Tietge U.J., Böker K.H., Manns M.P., Bahr M.J. Elevated circulating adiponectin levels in liver cirrhosis are associated with reduced liver function and altered hepatic hemodynamics. Am J Physiol Endocrinol Metab 2004, 287:E82-E89.
6. Otero M., Lago R., Gomez R., et al. Changes in plasma levels of fat-derived hormones adiponectin, leptin, resistin and visfatin in patients with rheumatoid arthritis. Ann Rheum Dis 2006, 65:1198-1201.
7. Karmiris K., Koutroubakis I.E., Xidakis C., Polychronaki M., Voudouri T., Kouroumalis E.A. Circulating levels of leptin, adiponectin, resistin, and ghrelin in inflammatory bowel disease. Inflamm Bowel Dis 2006, 12:100-105.
8. Sada K.E., Yamasaki Y., Maruyama M., et al. Altered levels of adipocytokines in association with insulin resistance in patients with systemic lupus erythematosus. J Rheumatol 2006, 33:1545-1552.
9. Frystyk J., Berne C., Berglund L., Jensevik K., Flyvbjerg A., Zethelius B. Serum adiponectin is a predictor of coronary heart disease: a population-based 10-year follow-up study in elderly men. J Clin Endocrinol Metab 2007, 92:571-576.
10. Pischon T., Girman C.J., Hotamisligil G.S., Rifai N., Hu F.B., Rimm E.B. Plasma adiponectin levels and risk of myocardial infarction in men. JAMA 2004, 291:1730-1737.
11. Chen M.P., Tsai J.C., Chung F.M., et al. Hypoadiponectinemia is associated with ischemic cerebrovascular disease. Arterioscler Thromb Vasc Biol 2005, 25:821-826.
12. Marousi S., Theodorou G., Karakantza M., Papathanasopoulos P., Ellul J. Serum adiponectin acutely after an ischemic stroke: implications for a long-lasting, suppressed anti-inflammatory role. Acta Neurol Scand 2010, 121:277-284.
13. Yatomi K., Miyamoto N., Komine-Kobayashi M., et al. Pathophysiological dual action of adiponectin after transient focal ischemia in mouse brain. Brain Res 2009, 1297:169-176.
14. Takeuchi S., Wada K., Nawashiro H., et al. Decrease in plasma adiponectin level and increase in adiponectin immunoreactivity in cortex and hippocampus after traumatic brain injury in rats. Turk Neurosurg 2013, 23:349-354.
15. Nagasawa H., Yokota C., Toyoda K., Ito A., Minematsu K. High level of plasma adiponectin in acute stroke patients is associated with stroke mortality. J Neurol Sci 2011, 304:102-106.
16. Wang W.H., Yu W.H., Dong X.Q., et al. Plasma adiponectin as an independent predictor of early death after acute intracerebral hemorrhage. Clin Chim Acta 2011, 412:1626-1631.
17. Juul N., Morris G.F., Marshall S.B., Marshall L.F. Intracranial hypertension and cerebral perfusion pressure: influence on neurological deterioration and outcome in severe head injury. The Executive Committee of the International Selfotel Trial. J Neurosurg 2000, 92:1-6.
18. Marshall L.F., Marshall S.B., Klauber M.R., Clark M.V. A new classification of head injury based on computerized tomography. J Neurosurg 1991, 75:S14-S20.
19. Wang K.Y., Yu G.F., Zhang Z.Y., Huang Q., Dong X.Q. Plasma high-mobility group box 1 levels and prediction of outcome in patients with traumatic brain injury. Clin Chim Acta 2012, 413:1737-1741.
20. Chen B., Liao W.Q., Xu N., et al. Adiponectin protects against cerebral ischemia-reperfusion injury through anti-inflammatory action. Brain Res 2009, 1273:129-137.
21. Nishimura M., Izumiya Y., Higuchi A., et al. Adiponectin prevents cerebral ischemic injury through endothelial nitric oxide synthase dependent mechanisms. Circulation 2008, 117:216-223.
22. Qi Y., Takahashi N., Hileman S.M., et al. Adiponectin acts in the brain to decrease body weight. Nat Med 2004, 10:524-529.
23. McEntegart M.B., Awede B., Petie M.C., et al. Increase in serum adiponectin concentration in patients with heart failure and cachexia: relationship with leptin, other cytokines, and B-type natriuretic peptide. Eur Heart J 2007, 28:829-835.
24. Dekker J.M., Funahashi T., Nijpels G., et al. Prognostic value of adiponectin for cardiovascular disease and mortality. J Clin Endocrinol Metab 2008, 93:1489-1496.
25. Kizer J.R., Barzilay J.I., Kuller L.H., Gottdiener J.S. Adiponectin and risk of coronary heart disease in older men and women. J Clin Endocrinol Metab 2008, 93:3357-3364.
26. Pilz S., Mangge H., Wellnitz B., et al. Adiponectin and mortality in patients undergoing coronary angiography. J Clin Endocrinol Metab 2006, 91:4277-4286.
27. Schnabel R., Messow C.M., Lubos E., et al. Association of adiponectin with adverse outcome in coronary artery disease: results from the AtheroGene study. Eur Heart J 2008, 29:649-657.
28. Cavusoglu E., Ruwende C., Chopra V., et al. Adiponectin is an independent predictor of all-cause mortality, cardiac mortality, and myocardial infarction in patients presenting with chest pain. Eur Heart J 2006, 27:2300-2309.